Yin Deng-Ping, Ma Lian-Li, Sankary Howard N, Shen Jikun, Zeng Huasong, Varghese Anncy, Chong Anita S
Department of General Surgery, Section of Transplantation, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA.
Transplantation. 2002 Nov 15;74(9):1236-41. doi: 10.1097/00007890-200211150-00007.
We studied the ability of CD4 and CD8 T cells to induce rejection of pancreas xenografts in a concordant combination using rat pancreas xenografts as donors and chemically induced diabetic mice as recipients.
Lewis rat (2 to 3 weeks old) pancreas xenografts were transplanted into streptozotocin (STZ)-induced diabetic mice. Lymphocyte proliferation and cytokine production were analyzed in vitro. All pancreas xenografts were assessed by functional (blood glucose) and histopathologic examinations.
Lewis rat pancreas grafts were rejected within 10 to 13 days, with mononuclear cell infiltrate and tissue necrosis in STZ-induced diabetic mice. A predominant T cell receptor alphabeta -CD4 cell (on day 4) and T cell receptor alphabeta -CD8 cell (on day 8) infiltrate and IgM deposition were found in the pancreas xenografts after transplantation. Anti-CD4 (GK1.5), but not anti-CD8 (YTS169.4), monoclonal antibodies resulted in a prolonged survival of Lewis rat pancreas xenografts. Lewis pancreas xenografts were permanently accepted by CD4 knockout mice but not by CD8 knockout mice. The pancreas xenografts were acutely rejected with a mean survival time of 15.3 days in B cell-deficient mice (microMT/microMT). Transfer of CD4 but not CD8 spleen cells from naïve C57BL/6 mice into Rag2 mice led to acute rejection of transplanted pancreas xenografts. However, activated CD8 spleen cells elicited rejection of Lewis rat pancreas xenografts in SZT-induced diabetic mice.
The current results show that CD4 T cells are necessary and sufficient for mediating the rejection of Lewis rat pancreas xenografts in STZ-induced diabetic mice. However, CD8 cells, when activated, can also induce acute rejection of concordant pancreas xenografts.
我们利用大鼠胰腺异种移植作为供体、化学诱导的糖尿病小鼠作为受体,以协调组合的方式研究了CD4和CD8 T细胞诱导胰腺异种移植排斥反应的能力。
将Lewis大鼠(2至3周龄)胰腺异种移植到链脲佐菌素(STZ)诱导的糖尿病小鼠体内。体外分析淋巴细胞增殖和细胞因子产生情况。所有胰腺异种移植均通过功能(血糖)和组织病理学检查进行评估。
Lewis大鼠胰腺移植物在10至13天内被排斥,STZ诱导的糖尿病小鼠出现单核细胞浸润和组织坏死。移植后在胰腺异种移植物中发现主要的T细胞受体αβ - CD4细胞(第4天)和T细胞受体αβ - CD8细胞(第8天)浸润以及IgM沉积。抗CD4(GK1.5)单克隆抗体而非抗CD8(YTS169.4)单克隆抗体导致Lewis大鼠胰腺异种移植物存活时间延长。Lewis胰腺异种移植物被CD4基因敲除小鼠永久接受,但未被CD8基因敲除小鼠接受。在B细胞缺陷小鼠(microMT/microMT)中,胰腺异种移植物被急性排斥,平均存活时间为15.3天。将未活化的C57BL/6小鼠的CD4而非CD8脾细胞转移到Rag2小鼠中导致移植的胰腺异种移植物急性排斥。然而,活化的CD8脾细胞在STZ诱导的糖尿病小鼠中引发Lewis大鼠胰腺异种移植物的排斥反应。
当前结果表明,CD4 T细胞对于介导STZ诱导的糖尿病小鼠中Lewis大鼠胰腺异种移植物的排斥反应是必要且充分的。然而,CD8细胞活化后也可诱导协调的胰腺异种移植物急性排斥反应。